Nano-X Imaging (NNOX) Net Cash Flow (QoQ) (2021 - 2026)
Nano-X Imaging (NNOX) Net Cash Flow (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Nano-X Imaging | 61,578.01 | -44.16 Mn | -2.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -232.03% |
| Dec 31, 2025 | 184.17% |
| Sep 30, 2025 | -149.22% |
| Jun 30, 2025 | 808.39% |
| Mar 31, 2025 | -0.28% |
| Dec 31, 2024 | 238.00% |
| Sep 30, 2024 | 87.05% |
| Jun 30, 2024 | 48.17% |
| Mar 31, 2024 | -12.52% |
| Dec 31, 2023 | -141.48% |
| Sep 30, 2023 | 460.67% |
| Jun 30, 2023 | 597.62% |
| Mar 31, 2023 | 47.72% |
| Dec 31, 2022 | 85.25% |
| Sep 30, 2022 | -261.73% |
| Jun 30, 2022 | 72.95% |
| Mar 31, 2022 | -8.47% |
| Dec 31, 2021 | 72.58% |
| Sep 30, 2021 | 61.75% |
| Jun 30, 2021 | -1,867.40% |